Serina Therapeutics Inc (SER) — Financial Flexibility Index
Serina Therapeutics Inc (SER) has a Financial Flexibility Index of -0.35x as of September 2025. Free cash flow of $-3.84 Million (operating CF $-3.85 Million minus capex $13.00K) represents 0% of total liabilities ($10.82 Million). Check Serina Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Serina Therapeutics Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Serina Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Serina Therapeutics Inc.
Annual Financial Flexibility Index for Serina Therapeutics Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Serina Therapeutics Inc. Explore how well can Serina Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.75x | $-17.11 Million | $-17.14 Million | $6.22 Million | ▼ -5661.2% |
| 2023 | -0.05x | $-1.97 Million | $-2.48 Million | $41.26 Million | ▲ +52.4% |
| 2022 | -0.10x | $-2.07 Million | $-2.08 Million | $20.56 Million | ▲ +29.5% |
| 2021 | -0.14x | $-2.14 Million | $-2.25 Million | $15.03 Million | ▲ +83.0% |
| 2020 | -0.84x | $-7.80 Million | $-7.82 Million | $9.32 Million | ▲ +57.6% |
| 2019 | -1.97x | $-9.52 Million | $-10.16 Million | $4.83 Million | ▲ +21.1% |
| 2018 | -2.50x | $-6.10 Million | $-8.00 Million | $2.44 Million | ▲ +47.8% |
| 2017 | -4.79x | $-6.28 Million | $-6.29 Million | $1.31 Million | ▼ -1358.9% |
| 2016 | -0.33x | $-8.40 Million | $-8.43 Million | $25.60 Million | — |